Artificial intelligence is a growing part of today’s healthcare landscape, and the intersection of AI and healthcare is expected to grow to a $100 billion market opportunity by 2028. Companies seeking to develop or use AI technologies in the healthcare space must understand the rapidly evolving regulations concerning AI and the key IP and commercial issues that arise from using or deploying AI technologies.

In this 6th session of Wilson Sonsini’s Digital Health Series, we’ll cover:

• Opportunities and risks associated with AI technologies in the digital health industry

• FDA oversight of AI and related tools

• Key IP and commercial considerations related to the development or use of AI technologies

Please reach out to presenters for a copy of the slide deck.